Speaker: 

Cassandra Lombardo, PharmD, Resident, Geisinger - has nothing to disclose. 

Moderator: 

Tristan Maiers, PharmD, BCOP, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the incidence of fungal infections in patients with hematologic malignancy
• Identify infection risk in association with cancer type and regimen used
• Recognize antifungal agents used and their place in therapy
• Apply antifungal prophylaxis to a patient case

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Activity Director, Rajiv Panikkar, MD, Michele Long, MS, BSN, OCN, Jaime Weeder, CRNP, Christopher Kashi, PA-C and Caitlin McDonald, CPht, CVT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.